Companies: 10,795·Total market cap: $144.5T
Indivior PLC

Indivior PLC

INVVYOTCHealthcare
$21.85
+$0.00(+0.00%)
Market Cap$3.0B
P/E Ratio
52W High$75.65
52W Low$14.76
Overview

Indivior PLC (INVVY) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

invvy · pe ratio · data through Dec 31, 2022

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Indivior PLC (INVVY) measures how much investors pay for each dollar of the company's trailing earnings. INVVY's current PE ratio of 18.67x is calculated by dividing its stock price of $21.85 by its TTM earnings per share of $2.00. +149.0% elevated vs 5Y avg 7.5x

18.67x
P/E Ratio (TTM)+149.0%

Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31

Forward P/E
N/A
EPS (TTM)
$2.00
TTM · diluted EPS
PEG Ratio
0.01
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Indivior PLC SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2019 – 2022 · Annual
PE Ratio (TTM)
5Y Avg 7.5x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Indivior PLC
Indivior PLCYou
INVVY
$3.0B18.67x+11.5%$2.00
Alfresa Holdings Corporation
Alfresa Holdings Corporation
ARHCF
$2.2B8.15x-51.3%$231.09
Ascentage Pharma Group International
Ascentage Pharma Group International
ASPHF
$1.7BN/A-$3.40
Digital Utilities Ventures, Inc.
Digital Utilities Ventures, Inc.
DUTV
$1.9BN/A-$0.00
Galenica AG
Galenica AG
GALNF
$5.7B25.35x+51.3%$3.63
Karo Pharma AB (publ)
Karo Pharma AB (publ)
KARBF
$1.5BN/A
Mithra Pharmaceuticals S.A.
Mithra Pharmaceuticals S.A.
MITPF
$1.6BN/A-$2.51
Industry Average
2 peers with valid PE
16.75xbaseline

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 4 of 4 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2022-12-31Latest
FY2022
$-0.38
2021-12-31
FY2021
12.21x$1.41
2020-12-31
FY2020
$-1.01
2019-12-31
FY2019
2.79x$0.92

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Indivior PLC (INVVY) measures how much investors pay for each dollar of the company's trailing earnings. INVVY's current PE ratio of 18.67x is calculated by dividing its stock price of $21.85 by its TTM earnings per share of $2.00.

PE Ratio = Stock Price ÷ EPS (TTM)
= $21.85 ÷ $2.00 = 18.67x
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

INVVY pe ratio · 6 questions

INVVY's current PE ratio is 18.67x as of 2026-06-08, based on a stock price of $21.85 and TTM EPS of $2.00. Data sourced from Financial Modeling Prep via INVVY's SEC 10-K and 10-Q filings.

INVVY PE ratioWhat is INVVY PE ratioCurrent PE ratio of INVVYINVVY PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Indivior PLC SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08